IUPAC and Gedeon Richter, Plc. are pleased to announce the 2018 IUPAC-Richter Prize in Medicinal Chemistry. The Prize was established in 2006 by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health. The prize – USD 10000 – is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery. Previous IUPAC-Richter Prizes were awarded to Malcolm F.G. Stevens in 2006, Jan Heeres in 2008, Arun K. Ghosh in 2010, Stephen Hanessian in 2012, Helmut Buschmann in 2014, and Michael J Sofia in 2016.
For earlier announcements including awardees presentation, visit this page.
The 2018 IUPAC-Richter Prize will be presented during the 36th National Medicinal Chemistry Symposium (29 April – 2 May 2018) on Medicinal Chemistry in Nashville, Tennessee (USA), where the recipient will also give a plenary lecture on the subject of his/her research.
Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain
- a complete resume,
- a professional autobiography of not more than two pages, and
- a one-page summary of what the individual considers to be his/her activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry.
The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Drug Discovery and Development.
Nomination materials should be submitted by 15 December 2017 through this Nomination Form.
For further information please contact Professor Janos Fischer, Chair of the IUPAC Subcommittee on Drug Discovery and Drug Development, by email at <email@example.com>.